Related Experiment Video
Updated: Dec 29, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
Developing a virus-microRNA interactome using cytoscape
Meredith Hill1, Dayna Mason1, Tânia Monteiro Marques2
1School Biomedical Engineering, University of Technology Sydney, NSW, Australia.
Abstract:
It is currently difficult to determine the effect of oncogenic viruses on the global function and regulation of pathways within mammalian cells. A thorough understanding of the molecular pathways and individual genes altered by oncogenic viruses is needed for the identification of targets that can be utilised for early diagnosis, prevention, and treatment methods. We detail a logical step-by-step guide to uncover viral-protein-miRNA interactions using publically available datasets and the network building program, Cytoscape. This method may be applied to identify specific pathways that are altered in viral infection, and contribute to the oncogenic transformation of cells. To demonstrate this, we constructed a gene regulatory interactome encompassing Human Papillomavirus Type 16 (HPV16) and its control of specific miRNAs. This approach can be broadly applied to understand and map the regulatory functions of other oncogenic viruses, and determine their role in altering the cellular environment in cancer. Availability and Implementation Cytoscape (Shannon et al. (2003), Smoot et al. (2010)) is freely available at https://cytoscape.org/. •This method allows for the analysis and visualization of large datasets to generate an interactome that integrates key players of molecular biology•This approach may be applied to any oncogenic virus to map its regulatory functions, and its secondary impact on gene regulation via microRNAs.
Insights
This study presents a method to analyze oncogenic virus-protein-miRNA interactions using Cytoscape. This approach helps identify cellular pathways altered by viruses, aiding in cancer diagnosis and treatment.
Area of Science:
- Molecular biology
- Virology
- Bioinformatics
Background:
- Oncogenic viruses significantly impact mammalian cell pathways, but their global effects are poorly understood.
- Identifying molecular targets is crucial for developing early diagnosis, prevention, and treatment strategies for virus-associated cancers.
- Current methods lack comprehensive approaches to map viral interactions and their downstream effects on cellular regulation.
Purpose of the Study:
- To provide a step-by-step guide for uncovering viral-protein-miRNA interactions using public datasets and Cytoscape.
- To enable the identification of specific cellular pathways dysregulated by oncogenic viruses.
- To demonstrate the utility of this method by constructing a gene regulatory interactome for Human Papillomavirus Type 16 (HPV16).
Main Methods:
- Utilizing publicly available datasets to identify viral proteins and their interacting microRNAs (miRNAs).
- Employing the network visualization and analysis software Cytoscape to build gene regulatory interactomes.
- Integrating data to map the interactions between viral proteins, miRNAs, and host cell genes.
Main Results:
- A gene regulatory interactome for HPV16 and its regulated miRNAs was successfully constructed.
- The method demonstrated the ability to visualize and analyze complex molecular interactions.
- The approach facilitates the mapping of viral regulatory functions and their impact on host gene expression.
Conclusions:
- The developed method offers a robust framework for analyzing viral-host interactions at the molecular level.
- This approach can be broadly applied to study other oncogenic viruses and their roles in cellular transformation.
- Understanding these interactions is key to identifying novel therapeutic targets and improving cancer management strategies.
Related Concept Videos
MicroRNAs
MicroRNAs
Viruses with RNA Genomes
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Protein-protein Interfaces

